Celularity (CELU) EV to EBITDA (2019 - 2025)

Celularity (CELU) has reported EV to EBITDA for 7 consecutive years, with 1.17 the latest figure, recorded in Q4 2025.

• On a quarterly basis, EV to EBITDA rose 82.71% year-over-year to 1.17 in Q4 2025; TTM through Dec 2025 was 0.42, a 74.28% increase from a year earlier, with the FY2025 full-year figure at 0.42, up 74.28% from the prior year.
• EV to EBITDA was 1.17 for Q4 2025 at Celularity, up from 4.52 in the prior quarter.
• Over five years, EV to EBITDA peaked at 106.85 in Q2 2022 and troughed at 51.58 in Q3 2022.
• A 5-year average of 1.13 and a median of 4.77 in 2025 frame the typical range for EV to EBITDA.
• Across the five-year window, EV to EBITDA soared 1904.94% in 2022 and plunged 1727.38% in 2024, its largest moves.
• Over 5 years, EV to EBITDA stood at 20.47 in 2021, then soared by 149.76% to 10.19 in 2022, then plunged by 64.88% to 3.58 in 2023, then slumped by 289.29% to 6.77 in 2024, then soared by 82.71% to 1.17 in 2025.
• The last three EV to EBITDA figures came in at 1.17 (Q4 2025), 4.52 (Q3 2025), and 3.72 (Q2 2025), per Business Quant data.